Passive immunotherapeutic strategies for the treatment of malignant gliomas

Neurosurg Clin N Am. 2012 Jul;23(3):481-95. doi: 10.1016/j.nec.2012.04.008.

Abstract

This review provides historical and recent perspectives related to passive immunotherapy for high-grade gliomas. The authors discuss approaches that use lymphokine-activated killer cells, cytotoxic T lymphocytes, and monoclonal antibodies.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Brain Neoplasms / immunology
  • Brain Neoplasms / therapy*
  • Cytokine-Induced Killer Cells / immunology
  • Glioblastoma / immunology
  • Glioblastoma / therapy*
  • Humans
  • Immunization, Passive / methods*
  • Immunotherapy, Adoptive / methods*
  • Radioimmunotherapy / methods
  • T-Lymphocytes, Cytotoxic / immunology
  • Tumor Escape

Substances

  • Antibodies, Monoclonal